02202 Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

0 Analyst Rating

Wall Street analysts forecast 02202 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02202 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

HSBC

HSBC Global Research

Buy

maintain

2025-12-01

Reason

HSBC

HSBC Global Research

Price Target

2025-12-01

maintain

Buy

Reason

The analyst rating for BOC HONG KONG was maintained at "Buy" by HSBC Global Research despite concerns about its exposure to CHINA VANKE. The reasoning behind this rating includes the belief that the likelihood of BOC HONG KONG downgrading its exposure to CHINA VANKE to Stage 3 before the end of 2025 is low, primarily due to the 30-day grace period on domestic bonds. Additionally, while there is an expectation of increased credit cost provisions in the future, the base scenario suggests that any significant classification of loans as Stage 3 would not occur until 2026. This indicates a level of confidence in BOC HONG KONG's current financial stability and management of risks associated with its lending practices. However, the target price was adjusted downwards from $45.2 to $43.2, reflecting the evolving situation and potential risks.

CLSA

Buy

downgrade

2025-11-28

Reason

CLSA

Price Target

2025-11-28

downgrade

Buy

Reason

The analyst rating for CHINA VANKE (02202.HK) is negatively impacted due to the company's request to extend the maturity of RMB2 billion medium-term notes, which is the first time it has sought an extension for public market bonds. This event is expected to negatively affect short-term sentiment in the real estate sector. Additionally, BOC HONG KONG (02388.HK) is perceived to have a relatively large exposure to Vanke's debt risk, which contributes to the cautious outlook. Despite this, BOC HONG KONG's EPS forecast for 2025 remains largely intact, although the 2026 EPS forecast was revised down by 2%, leading to a lowered target price but a maintained Buy rating.

Daiwa

downgrade

2025-11-28

Reason

Daiwa

Price Target

2025-11-28

downgrade

Reason

The analyst rating for CHINA VANKE (02202.HK) was set to "Underperform" due to several key reasons outlined in the article. The company’s unexpected application to delay the repayment of RMB2 billion medium-term notes raised concerns in the market, as it may be perceived as a de facto default despite the possibility of negotiating an extension. This situation is likely to weaken Vanke's future sales and refinancing outlook, as it could erode confidence among stakeholders such as regulators, creditors, homebuyers, and suppliers. The broker, Daiwa, noted that this could lead the company into a vicious cycle of declining trust and financial instability. While there is a possibility of receiving assistance due to Vanke's benchmark status in the industry, the expectation of a market-oriented solution like debt restructuring further supports the negative outlook.

Morgan Stanley

Equalweight

downgrade

2025-10-16

Reason

Morgan Stanley

Price Target

2025-10-16

downgrade

Equalweight

Reason

The analyst rating from Morgan Stanley for CHINA VANKE (02202.HK) was lowered due to weak property sales and lower gross profit margins. The broker reduced its 2025 property sales forecast by 14%, indicating a significant decline in sales and a depletion of land reserves. Additionally, changes in booking led to lowered revenue forecasts for the following years, resulting in increased net loss forecasts. Consequently, the target price was cut from $4.65 to $4.28, while maintaining an Equalweight rating.

Citi Research

Neutral

maintain

$5.47

2025-08-25

Reason

Citi Research

Price Target

$5.47

2025-08-25

maintain

Neutral

Reason

The analyst rating for CHINA VANKE was maintained at Neutral by Citi Research due to several factors. The company has received short-term relief from its parent company, the government, and banks, which is expected to support its operations. Additionally, there is no offshore public debt maturing before 2027, allowing the company some financial breathing room. CHINA VANKE is also taking steps to streamline its core business, optimize its capital structure, and enhance operational efficiency through technological upgrades. Despite a projected 38% drop in annual delivery volume and an expected net loss in 2025, these positive developments led the broker to keep the rating at Neutral, with a target price of $5.47.

Valuation Metrics

The current forward P/E ratio for CHINA VANKE (02202.HK) is -2.31, compared to its 5-year average forward P/E of 2.40. For a more detailed relative valuation and DCF analysis to assess CHINA VANKE 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

2.40

Current PE

-2.31

Overvalued PE

8.69

Undervalued PE

-3.88

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

87.19

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

785.14

Undervalued EV/EBITDA

-610.77

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.38

Current PS

0.00

Overvalued PS

0.50

Undervalued PS

0.25

Financials

Annual

Quarterly

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

02202 News & Events

Events Timeline

No data

News

4.0

03:11 AMaastocks

6.5

03:09 AMaastocks

BofAS Predicts Stricter Chinese Property Regulations by March/April, Prefers CR Land and COLI

7.0

01-07aastocks

China Vanke Receives Approval from Chinese Banks to Postpone Interest Payments and Prevent Default: Report

People Also Watch

Frequently Asked Questions

What is CHINA VANKE (02202) stock price today?

The current price of 02202 is 3.5 USD — it has increased 4.48 % in the last trading day.

What is CHINA VANKE (02202)'s business?

What is the price predicton of 02202 Stock?

Wall Street analysts forecast 02202 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02202 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CHINA VANKE (02202)'s revenue for the last quarter?

CHINA VANKE revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is CHINA VANKE (02202)'s earnings per share (EPS) for the last quarter?

CHINA VANKE. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for CHINA VANKE (02202)'s fundamentals?

The market is revising No Change the revenue expectations for 02202 for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by %.

How many employees does CHINA VANKE (02202). have?

CHINA VANKE (02202) has 0 emplpoyees as of January 08 2026.

What is CHINA VANKE (02202) market cap?

Today 02202 has the market capitalization of 0.00 USD.